Company profile: Impopharma
1.1 - Company Overview
Company description
- Provider of comprehensive drug product formulation and process development, along with wide-ranging analytical testing services for the pharmaceutical industry, specializing in nasal and pulmonary drug products.
Products and services
🔒
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Impopharma
Marvel Biotechnology
HQ: Canada
Website
- Description: Provider of biotech discovery and development of synthetic derivatives of proven drugs, including MB-204, a fluorinated derivative of istradefylline, for neurological diseases (depression, anxiety, Alzheimer's, ADHD), liver fibrosis due to NASH, and adjunctive cancer therapies.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Marvel Biotechnology company profile →
Eucodis Bioscience
HQ: Austria
Website
- Description: Provider of high-performance enzyme solutions, offering enzyme engineering for industrial customers across the chemical, pharmaceutical, cosmetics, and food and feed industries.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Eucodis Bioscience company profile →
BioMedion
HQ: Germany
Website
- Description: Provider of compliance management software and services for the highly regulated life science industry, medicines agencies, and national competent authorities. Offers GxP quality, compliance, and archiving solutions, including neuronOS, IMAGE+, WATCH+, regulatory operations services, raw data archiving, and subject-matter expertise, computer system validation, and training management.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full BioMedion company profile →
Berkshire Sterile Manufacturing
HQ: United States
Website
- Description: Provider of small-scale sterile manufacturing services for clinical use, delivering the safest sterile drug products with the highest level of sterility assurance and quality through modern sterile manufacturing technologies.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Berkshire Sterile Manufacturing company profile →
Adalvo
HQ: Malta
Website
- Description: Provider of B2B pharmaceutical products and services, part of Alvogen Group and powered by Alvogen and Alvotech. Offers 90+ specialty generic small-molecule products across Oncology, Women’s Health, Cardiovascular and CNS; 15+ value-added 505(b)(2) CNS therapies; and 8+ peptide products for Rare Diseases and Diabetes. Develops Fidaxomicin 200 mg tablets, Ethinylestradiol/Drospirenone, and Dimethyl Fumarate for RRMS.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Adalvo company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Impopharma
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Impopharma
2.2 - Growth funds investing in similar companies to Impopharma
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Impopharma
4.2 - Public trading comparable groups for Impopharma
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →